Indica Labs’ Boston HALO® User Group Meeting

Date: 12 May 2026
Time: 12:00 PM – 4:20 PM
Location: Le Méridien Boston Cambridge

Learn about the latest advancements from Indica Labs and how our customers are leveraging HALO platforms and Indica Labs services to advance their digital pathology.

Summary

Indica Labs is pleased to announce our Boston HALO® User Group Meeting at Le Méridien Boston Cambridge on 12 May from 12:00 PM – 4:20 PM.

Our program this year features two exciting workflow-focused pre-event workshops, guest speakers sharing insightful real-world applications of our HALO platforms, and presentations from Indica Labs exploring the latest advancements in image analysis, image management, and services.

We welcome anyone who is interested in learning more about Indica Labs’ quantitative digital pathology solutions to register for the meeting today and save your place. You do not need to be a current Indica Labs customer to attend.

Presenters

Agenda

Time

Topic

Presenters

9:30 - 10:10

Masterclass: HALO AI: Designing Effective Analysis Pipelines

Spencer Revill

Field Applications Scientist

Indica Labs


Biography

Spencer Revill is a Field Application Scientist at Indica Labs supporting digital pathology and image analysis with a background in biotechnology and medical sciences. Prior to joining Indica, he managed a translational research core facility and conducted graduate research in lung pathology using digital image analysis. Spencer now works closely with customers to support evaluations, proof‑of‑concept studies, and adoption of HALO, HALO AI, and HALO Link across a wide range of research applications. His work focuses on helping researchers translate complex image data into reliable, reproducible insights using digital pathology.

10:20 - 11:00

Hidden Gems of HALO: Unique Workflows You're Not Using (Yet)

Alyssa Myers

Director, Customer & Product Training

Indica Labs


Biography

Alyssa has a background in neuroscience and psychology with an MSc. in Biomedical Sciences from the Lewis Katz School of Medicine at Temple University, where she explored the effects of cannabinoids on neuropathic pain. 


After joining Indica Labs as a Field Application Scientist in 2017, she demonstrated a deep commitment to scientific advancement and customer support, guiding customers through complex training on HALO, HALO AI, and HALO Link. 


Alyssa was promoted to Director of Customer and Product Training in 2022. In her current role at Indica Labs, she oversees the development and execution of training programs that empower customers to fully leverage Indica's advanced image analysis solutions, furthering the impact of their work in digital pathology. 


Alyssa’s journey reflects her passion for continuous learning, innovation, and enhancing user experience in the scientific community.


11:00 - 12:00

Registration

12:00 – 12:10

Welcome Address

Eileen Regan

VP, Life Science Applications

Indica Labs 

12:10 – 12:30

Unlocking the Potential of Antibody-Drug Conjugates with the HALO ADC Target Module

Emily Gamble

Associate Product Manager

Indica Labs


Biography

Emily Gamble has a background in education and neuroscience. She received her M.S. in Neuroscience from Tulane University in New Orleans, LA. Emily joined the Product Management team at Indica Labs as the HALO Product Specialist in 2020 and was promoted to HALO Associate Product Manager in 2023. In her current role, she works closely with customers and software engineers at all stages of product development to enhance the image analysis experience in HALO®.

12:30 1:00

Integrating HALO and HALO Link in a GLP-Compliant CRO: Real-World Insights from a Multi-Client Environment

Elizabeth Chlipala, BS, HTL(ASCP)QIHC 

President

Premier Laboratory, LLC


Biography

Elizabeth Ann Chlipala, BS, HTL(ASCP), QIHC(ASCP), is a histotechnologist and laboratory leader with more than 40 years of experience in histology, immunohistochemistry, digital pathology, and GLP/GMP-regulated environments. She is currently President and Laboratory Manager at Premier Laboratory, LLC in Longmont, Colorado, where she oversees laboratory operations, assay development, and image analysis workflows supporting diverse research programs.

Ms. Chlipala earned her Bachelor of Science in Biology from Oakland University and completed her histotechnology training at William Beaumont Hospital. She has held leadership roles across hospital, industry, and CRO settings, including positions at BolderPATH, Amgen Boulder, Hinsdale Hospital, and Sinai Hospital of Detroit.

She has authored or co-authored more than 45 peer-reviewed publications and 25 abstracts, with a focus on IHC assay development, digital pathology validation, and laboratory quality systems. An internationally recognized speaker, she has delivered over 190 presentations on topics including protocol optimization, image analysis, and GLP compliance.

Ms. Chlipala is deeply engaged in professional service, including leadership roles within the National Society for Histotechnology, editorial contributions to the Journal of Histotechnology, and participation in CAP and Digital Pathology Association initiatives. 

1:00 - 2:00

Lunch


2:00 - 2:30

Understanding Senescence Using Spatial Biology 

Imdadul Haq, PH.D

Associate Research Scientist

Columbia University

Biography

Dr. Imdadul Haq holds a joint appointment as an Associate Research Scientist in the Department of Neurology at Columbia University and the New York Genome Center in New York. His research investigates the mechanisms by which proteopathy disrupts molecular homeostasis during aging and disease progression. He specializes in integrating spatial transcriptomics, proteomics, advanced imaging, and functional genomics to examine cellular heterogeneity in human brain tissue. A primary objective of his research is to elucidate neuroglial interactions within the human brain microenvironment during aging and neurodegeneration.

2:30 - 2:55

Revealing Deeper Insights Using HALO High Dimensional Analysis 

Maciej Zerkowski

Life Science Applications Manager

Indica labs


Biography

Maciej manages the North American field applications team in the US and Canada, which provides applications and sales support for Indica Labs’ customers. He has earned a Bachelor of Science degree in Molecular and Cell Biology at the University of Connecticut, whereupon he began his professional career as a Research Assistant at Yale University, working on a then novel fluorescence-based automated quantitative image analysis (AQUA) technology. He subsequently joined HistoRx, a start-up founded to commercialize the AQUA platform, where he had the opportunity to help guide its development from a temperamental academic project into a robust and successful commercial product. Following the sale of HistoRx, he began work as a Field Application Scientist at Cambridge Research and Instrumentation, a biotechnology startup focused on multispectral imaging and analysis of tissue samples, which was eventually acquired by PerkinElmer, a global life sciences corporation. Prior to joining Indica Labs in 2022, Maciej was the lead Field Applications Scientist at Ionpath, where he worked with Ionpath’s proprietary Multiplexed Ion Beam Imaging (MIBI) technology, a mass spectrometry imaging device enabling the simultaneous quantitation of up to 40 antibody markers on tissue sections.

2:55 - 3:15

Coffee break and Networking

3:15 –3:45

Integrating Digital Pathology and Acrivon Predictive Precision Proteomics (AP3) to Understand Drug Mechanisms and Patient Outcomes

Kate Rappard, B.S.

Associate Scientist

Acrivon Therapeutics


Biography

Kate Rappard is a scientist specializing in oncology-focused translational research and biomarker assay development. With over seven years of experience across biotech and academic settings, she has developed strong expertise in immunodetection techniques, image analysis, and experimental design. She currently serves as an Associate Scientist at Acrivon Therapeutics, where she leads efforts to design and optimize assays, identify predictive biomarkers, and support the development of novel cancer therapeutics.

Rappard earned her Bachelor of Science in Human Biology from the University of Southern California, where she conducted extensive research on circulating tumor cell characterization using liquid biopsies. Her work has contributed to multiple peer-reviewed publications in leading scientific journals. 

In addition to her research career, she has held roles in federal service and community engagement, including work with the Federal Bureau of Investigation and volunteer leadership as a ski instructor for underserved youth. Known for her collaborative approach and strong communication skills, Rappard is passionate about advancing science to improve patient outcomes and broaden community impact.

3:45 – 4:15

Powering Discovery in Life Science: Upcoming Features and Developments in HALO, HALO AI, and HALO Link

Levi Maston, PhD

Sr. Field Applications Scientist

Indica Labs


Biography

Dr. Maston earned his BS in Biochemistry from New Mexico State University and his PhD in Biomedical Sciences from the University of New Mexico School of Medicine, where he focused on vascular physiology and immunology. He followed his fascination with the tumor microenvironment from graduate school to his current role at Indica Labs. In his spare time, Levi enjoys the outdoors of the beautiful southwestern US, and can be found anywhere from whitewater rafting with his son in Durango Colorado, to racing drones at the International balloon fiesta park in Albuquerque, NM.

4:15 – 4:20

Closing Remarks

Eileen Regan

VP, Life Science Applications

Indica Labs

Scroll to Top